Vimta Labs declines amid volatility

Vimta Labs lost 2.4% to Rs 126.15 at 15:12 IST on BSE, with the stock witnessing intraday volatility after the company reported Q4 March 2017 earnings.

Meanwhile, the S&P BSE Sensex was up 297.08 points or 1.01% at 29,662.38. The S&P BSE Small-Cap index was up 133.35 points or 0.88% at 15,299.66.

On the BSE, 51,000 shares were traded on the counter so far as against the average daily volumes of 48,633 shares in the past one quarter. The stock lost as much as 2.4% at the day's low of Rs 126.15 so far during the day. The stock rose as much as 3.59% at the day's high of Rs 133.90 so far during the day.

The stock had hit a 52-week high of Rs 138.60 on 19 April 2017 and a 52-week low of Rs 67.65 on 24 June 2016. It had outperformed the market over the past one month till 21 April 2017, advancing 17.55% compared with the Sensex's 0.41% fall. The scrip had also outperformed the market over the past one quarter, gaining 24.94% as against the Sensex's 8.62% rise.

The small-cap company has equity capital of Rs 4.42 crore. Face value per share is Rs 2.

Vimta Labs' net profit rose 32.6% to Rs 2.40 crore on 19.9% growth in net sales to Rs 39.47 crore in Q4 March 2017 over Q4 March 2016. The result was announced on Saturday, 22 April 2017.

Vimta Labs is engaged in the business of contract research and testing services. The company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.

Powered by Capital Market - Live News